Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor

T.J.N. Hiltermann, M.M. Pore, A. van den Berg, W. Timens, H.M. Boezen, J.J.W. Liesker, J.H. Schouwink, W.J.A. Wijnands, G.S.M.A. Kerner, F.A.E. Kruyt, H. Tissing, A.G.J. Tibbe, L.W.M.M. Terstappen, H.J.M. Groen

Research output: Contribution to journalArticleAcademicpeer-review

143 Citations (Scopus)

Abstract

Background: Initial response of small-cell lung cancer (SCLC) to chemotherapy is high, and recurrences occur frequently, leading to early death. This study investigated the prognostic value of circulating tumor cells (CTCs) in patients with SCLC and whether changes in CTCs can predict response to chemotherapy.

Patients and methods: In this multicenter prospective study, blood samples for CTC analysis were obtained from 59 patients with SCLC before, after one cycle, and at the end of chemotherapy. CTCs were measured using CellSearch® systems.

Results: At baseline, lower numbers of CTCs were observed for 21 patients with limited SCLC (median = 6, range 0–220) compared with 38 patients with extensive stage (median = 63, range 0–14 040). Lack of measurable CTCs (27% of patients) was associated with prolonged survival (HR 3.4; P ≤ 0.001). CTCs decreased after one cycle of chemotherapy; this decrease was not associated with tumor response after four cycles of chemotherapy. CTC count after the first cycle of chemotherapy was the strongest predictor for overall survival (HR 5.7; 95% CI 1.7–18.9; P = 0.004).

Conclusion: Absolute CTCs after one cycle of chemotherapy in patients with SCLC is the strongest predictor for response on chemotherapy and survival. Patients with low initial CTC numbers lived longer than those with higher CTCs.
Original languageEnglish
Pages (from-to)2937-2942
JournalAnnals of oncology
Volume23
Issue number11
DOIs
Publication statusPublished - 11 Jun 2012

Keywords

  • IR-84085
  • METIS-289041

Fingerprint Dive into the research topics of 'Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor'. Together they form a unique fingerprint.

Cite this